Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial.

Witkiewitz K, Falk DE, Litten RZ, Hasin DS, Kranzler HR, Mann KF, O'Malley SS, Anton RF.

Alcohol Clin Exp Res. 2019 May;43(5):979-987. doi: 10.1111/acer.14018. Epub 2019 Apr 5.

2.

Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.

Falk DE, O'Malley SS, Witkiewitz K, Anton RF, Litten RZ, Slater M, Kranzler HR, Mann KF, Hasin DS, Johnson B, Meulien D, Ryan M, Fertig J; Alcohol Clinical Trials Initiative (ACTIVE) Workgroup.

JAMA Psychiatry. 2019 Apr 1;76(4):374-381. doi: 10.1001/jamapsychiatry.2018.3079.

PMID:
30865232
3.

Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder.

Witkiewitz K, Kranzler HR, Hallgren KA, O'Malley SS, Falk DE, Litten RZ, Hasin DS, Mann KF, Anton RF.

Alcohol Clin Exp Res. 2018 Dec;42(12):2453-2465. doi: 10.1111/acer.13897. Epub 2018 Nov 5.

PMID:
30395350
4.

Letter to Editor in Response to Johnson's Commentary (2017) on the Witkiewitz and Colleagues (2017) Article.

Litten RZ, Falk DE, O'Malley SS, Witkiewitz KA, Mann KF, Anton RF.

Alcohol Clin Exp Res. 2017 Jul;41(7):1381-1382. doi: 10.1111/acer.13411. Epub 2017 May 23. No abstract available.

5.

Psychiatric comorbidity in alcohol use disorders: results from the German S3 guidelines.

Preuss UW, Gouzoulis-Mayfrank E, Havemann-Reinecke U, Schäfer I, Beutel M, Hoch E, Mann KF.

Eur Arch Psychiatry Clin Neurosci. 2018 Apr;268(3):219-229. doi: 10.1007/s00406-017-0801-2. Epub 2017 Apr 24. Review.

PMID:
28439723
6.

Temporal Stability of Heavy Drinking Days and Drinking Reductions Among Heavy Drinkers in the COMBINE Study.

Witkiewitz K, Wilson AD, Pearson MR, Hallgren KA, Falk DE, Litten RZ, Kranzler HR, Mann KF, Hasin DS, O'Malley SS, Anton RF.

Alcohol Clin Exp Res. 2017 May;41(5):1054-1062. doi: 10.1111/acer.13371. Epub 2017 Apr 5.

7.

Negative Association Between MR-Spectroscopic Glutamate Markers and Gray Matter Volume After Alcohol Withdrawal in the Hippocampus: A Translational Study in Humans and Rats.

Frischknecht U, Hermann D, Tunc-Skarka N, Wang GY, Sack M, van Eijk J, Demirakca T, Falfan-Melgoza C, Krumm B, Dieter S, Spanagel R, Kiefer F, Mann KF, Sommer WH, Ende G, Weber-Fahr W.

Alcohol Clin Exp Res. 2017 Feb;41(2):323-333. doi: 10.1111/acer.13308. Epub 2017 Jan 18.

PMID:
28098946
8.

Deep grey matter iron accumulation in alcohol use disorder.

Juhás M, Sun H, Brown MRG, MacKay MB, Mann KF, Sommer WH, Wilman AH, Dursun SM, Greenshaw AJ.

Neuroimage. 2017 Mar 1;148:115-122. doi: 10.1016/j.neuroimage.2017.01.007. Epub 2017 Jan 5.

PMID:
28065850
9.

Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels.

Witkiewitz K, Hallgren KA, Kranzler HR, Mann KF, Hasin DS, Falk DE, Litten RZ, O'Malley SS, Anton RF.

Alcohol Clin Exp Res. 2017 Jan;41(1):179-186. doi: 10.1111/acer.13272. Epub 2016 Dec 26.

10.

Genome-wide association study of pathological gambling.

Lang M, Leménager T, Streit F, Fauth-Bühler M, Frank J, Juraeva D, Witt SH, Degenhardt F, Hofmann A, Heilmann-Heimbach S, Kiefer F, Brors B, Grabe HJ, John U, Bischof A, Bischof G, Völker U, Homuth G, Beutel M, Lind PA, Medland SE, Slutske WS, Martin NG, Völzke H, Nöthen MM, Meyer C, Rumpf HJ, Wurst FM, Rietschel M, Mann KF.

Eur Psychiatry. 2016 Aug;36:38-46. doi: 10.1016/j.eurpsy.2016.04.001. Epub 2016 Jun 14.

PMID:
27315593
11.

[Mental comorbidities of alcohol-related disorders].

Preuss UW, Gouzoulis-Mayfrank E, Havemann-Reinecke U, Schäfer I, Beutel M, Mann KF, Hoch E.

Nervenarzt. 2016 Jan;87(1):26-34. German.

PMID:
26493058
12.

Personality and substance use: psychometric evaluation and validation of the Substance Use Risk Profile Scale (SURPS) in English, Irish, French, and German adolescents.

Jurk S, Kuitunen-Paul S, Kroemer NB, Artiges E, Banaschewski T, Bokde AL, Büchel C, Conrod P, Fauth-Bühler M, Flor H, Frouin V, Gallinat J, Garavan H, Heinz A, Mann KF, Nees F, Paus T, Pausova Z, Poustka L, Rietschel M, Schumann G, Struve M, Smolka MN; IMAGEN consortium.

Alcohol Clin Exp Res. 2015 Nov;39(11):2234-48. doi: 10.1111/acer.12886. Epub 2015 Oct 14.

PMID:
26463560
13.

BRAIN NETWORKS. Correlated gene expression supports synchronous activity in brain networks.

Richiardi J, Altmann A, Milazzo AC, Chang C, Chakravarty MM, Banaschewski T, Barker GJ, Bokde AL, Bromberg U, Büchel C, Conrod P, Fauth-Bühler M, Flor H, Frouin V, Gallinat J, Garavan H, Gowland P, Heinz A, Lemaître H, Mann KF, Martinot JL, Nees F, Paus T, Pausova Z, Rietschel M, Robbins TW, Smolka MN, Spanagel R, Ströhle A, Schumann G, Hawrylycz M, Poline JB, Greicius MD; IMAGEN consortium.

Science. 2015 Jun 12;348(6240):1241-4. doi: 10.1126/science.1255905. Epub 2015 Jun 11.

14.

Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate.

Karpyak VM, Biernacka JM, Geske JR, Jenkins GD, Cunningham JM, Rüegg J, Kononenko O, Leontovich AA, Abulseoud OA, Hall-Flavin DK, Loukianova LL, Schneekloth TD, Skime MK, Frank J, Nöthen MM, Rietschel M, Kiefer F, Mann KF, Weinshilboum RM, Frye MA, Choi DS.

Transl Psychiatry. 2014 Oct 7;4:e462. doi: 10.1038/tp.2014.103.

15.

RASGRF2 regulates alcohol-induced reinforcement by influencing mesolimbic dopamine neuron activity and dopamine release.

Stacey D, Bilbao A, Maroteaux M, Jia T, Easton AC, Longueville S, Nymberg C, Banaschewski T, Barker GJ, Büchel C, Carvalho F, Conrod PJ, Desrivières S, Fauth-Bühler M, Fernandez-Medarde A, Flor H, Gallinat J, Garavan H, Bokde AL, Heinz A, Ittermann B, Lathrop M, Lawrence C, Loth E, Lourdusamy A, Mann KF, Martinot JL, Nees F, Palkovits M, Paus T, Pausova Z, Rietschel M, Ruggeri B, Santos E, Smolka MN, Staehlin O, Jarvelin MR, Elliott P, Sommer WH, Mameli M, Müller CP, Spanagel R, Girault JA, Schumann G; IMAGEN Consortium.

Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):21128-33. doi: 10.1073/pnas.1211844110. Epub 2012 Dec 5.

16.

Why should we need a European Federation of Addiction Societies?

Mann KF.

Addiction. 2012 Apr;107(4):692-3. doi: 10.1111/j.1360-0443.2011.03666.x. Epub 2012 Jan 18. No abstract available.

PMID:
22256948
17.

What works for patients in outpatient treatment for alcohol addiction? An explorative study into clients' evaluation of subjective factors and therapy satisfaction.

Frick KM, Loessl B, Brueck RK, Kriston L, Jaehne A, Riemann D, Gann H, Batra A, Wodarz N, Mann KF, Berner MM.

Subst Abuse. 2011;5:27-34. doi: 10.4137/SART.S6796. Epub 2011 May 29.

18.

Offspring of parents with an alcohol use disorder prefer higher levels of brain alcohol exposure in experiments involving computer-assisted self-infusion of ethanol (CASE).

Zimmermann US, Mick I, Laucht M, Vitvitskiy V, Plawecki MH, Mann KF, O'Connor S.

Psychopharmacology (Berl). 2009 Mar;202(4):689-97. doi: 10.1007/s00213-008-1349-7. Epub 2008 Oct 21.

PMID:
18936917
19.

Development and pilot validation of computer-assisted self-infusion of ethanol (CASE): a new method to study alcohol self-administration in humans.

Zimmermann US, Mick I, Vitvitskyi V, Plawecki MH, Mann KF, O'Connor S.

Alcohol Clin Exp Res. 2008 Jul;32(7):1321-8. doi: 10.1111/j.1530-0277.2008.00700.x.

PMID:
18540908
20.

Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial.

Soyka M, Koller G, Schmidt P, Lesch OM, Leweke M, Fehr C, Gann H, Mann KF; ACTOL Study Investigators.

J Clin Psychopharmacol. 2008 Jun;28(3):317-24. doi: 10.1097/JCP.0b013e318172b8bc.

PMID:
18480689
21.

How gene-stress-behavior interactions can promote adolescent alcohol use: the roles of predrinking allostatic load and childhood behavior disorders.

Zimmermann US, Blomeyer D, Laucht M, Mann KF.

Pharmacol Biochem Behav. 2007 Feb;86(2):246-62. Epub 2006 Nov 14. Review.

PMID:
17107706
22.

Low level of response to alcohol as associated with serotonin transporter genotype and high alcohol intake in adolescents.

Hinckers AS, Laucht M, Schmidt MH, Mann KF, Schumann G, Schuckit MA, Heinz A.

Biol Psychiatry. 2006 Aug 1;60(3):282-7. Epub 2006 Feb 21.

PMID:
16497275
23.

[Addiction medicine--the "delayed specialty"?].

Mann KF.

Nervenarzt. 2002 Jul;73(7):577-9. German. No abstract available.

PMID:
12212519
24.

Part of the invisible college.

Mann KF.

Addiction. 2001 May;96(5):682. No abstract available.

PMID:
11331026
25.

[Changes in the psychological state caused by autogenic training].

Schrapper DK, Mann KF.

Psychother Psychosom Med Psychol. 1985 Oct-Nov;35(10-11):268-72. German. No abstract available.

PMID:
4070527

Supplemental Content

Support Center